Lisvy
Recall
|
Medicines
|
18/10/2016
Gedeon Richter Plc has informed their supplied customers by letter dated 12/10/2016 that above mentioned batches of "Lisvy 60 microgram/24 hours + 13 microgram/24 hours Transdermal Patch" are recalled. Stability data for these batches indicated a more rapid decline of the active ingredient gestodene. Since there is no assurance that the active ingredient level will remain within specification until the expiration date, these lots are being recalled.
| Name of the medicinal product | Lisvy 60 Mikrogramm/24 Stunden + 13 Mikrogramm/24 Stunden Transdermales Pflaster |
|---|---|
| Marketing authorisation number(s) | 135535 |
| Marketing authorisation holder | Gedeon Richter Plc |
| Batch number(s) | V49315AR V49315AP V49315AS V49315CB V49315CA V49315CC V5A309AK V5A309AU V5A309BE V5A309CB V63303AE V49315AS V49315CC |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-1860 |
Further inquiry note
Page last modified:
12/07/2022